AstraZeneca becomes Britain’s first £200bn company

In This Article:

AstraZeneca boss Pascal Soriot with the then Prince Of Wales at AstraZeneca's global research and development facility in Cambridge, 2021
AstraZeneca boss Pascal Soriot with the then Prince Of Wales at AstraZeneca's global research and development facility in Cambridge, 2021 - Chris Jackson/Getty Images

AstraZeneca has become Britain’s first £200bn company following a 20pc rally in its share price since the start of the year.
Shares in the pharmaceutical business rose 1.1pc yesterday to value the company at £200.3bn.

AstraZeneca’s stock has surged so far this year amid strong sales of its roster of cancer and rare disease ­medicines. The drug company jumped ahead of Shell in April to become the most valuable business on the FTSE 100.

AstraZeneca surpassed its long-term revenue targets last year, generating $45.8bn  (£35.7bn) of sales compared with $25.7bn in 2014.

It said in May it was now targeting annual revenues of $80bn by 2030, claiming it was embarking on a “new era of growth”.

Pascal Soriot, the AstraZeneca chief executive, said many of the treatments it was developing had the potential to generate more than $5bn of revenue in a year.

It is aiming to launch a further 20 new medicines before the end of the decade.

As part of this push, AstraZeneca struck a £1.6bn deal in November for an experimental weight loss pill being developed by Chinese biotech company Eccogene.

Read the latest updates below.


06:29 PM BST

Signing off...

Thanks for joining us today. We’ll be back tomorrow morning with all the latest from the markets from around 7am.


06:29 PM BST

US stocks push higher amid rising hopes of a rate cut

US stocks are pushing higher after the fresh figures on the economy this week came in better than expected.

The S&P 500 is 1.4pc higher after the US government reported inflation at the wholesale level slowed last month by more than economists expected. The Dow Jones Industrial Average is up 0.8pc, while the Nasdaq Composite was 2.2pc higher.

High inflation has been the scourge of shoppers and financial markets for years. It finally looks to be slowing enough to get the Federal Reserve to ease up on high interest rates, which the Fed has been keeping at economy-crunching levels in order to stifle inflation.

Treasury yields eased in the bond market following the inflation data, as traders remain convinced the Fed’s meeting next month will bring the first cut to interest rates since the Covid crash of 2020.

The yield on benchmark 10-year US Treasury bonds fell to 3.85pc from 3.91pc late on Monday.


05:46 PM BST

Starbucks is a fast food restaurant that can learn from Chipotle, says analyst

We reported earlier on Starbucks’ appointment of Chipotle Mexican Grill boss Brian Niccol as its new chief executive.

Chipotle’s sales have surged since Mr Niccol joined in 2018, and the stock has more than tripled over the last five years.